この翻訳版は世界保健機関 (WHO) が作成したものではない. WHO はこの翻訳の内容や正確性
について責任を負わない. オリジナルの英語版 「2021 Antibacterial agents in clinical and …

Highlights•Carbapenem-resistant Gram-negative pathogens are a priority for R&D,
according to WHO.•Increasing need for new therapies against Klebsiella, Pseudomonas and …

Some rights reserved. This work is available under the Creative Commons Attribution-
NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https …

The discovery of antibiotics has long been regarded as one of the most significant medical
achievements of the twentieth century. Antibiotics have saved millions of lives (1) and …

2019 ANTIBACTERIAL AGENTS IN CLINICAL DEVELOPMENT Page 1 2019
ANTIBACTERIAL AGENTS IN CLINICAL DEVELOPMENT an analysis of the antibacterial …

Since the peak of the coronavirus disease 2019 (COVID-19) pandemic, concerns around
multidrug-resistant (MDR) bacterial pathogens have increased. This study aimed to …

Objectives This study investigated the occurrence of extended-spectrum β-lactamase
(ESBL) genes coexisting with carbapenemase, AmpC and aminoglycoside resistance gene …

Choosing the appropriate antibiotics to treat bacterial infections has grown more challenging
as a result of the emergence of antibiotic-resistant bacteria. Aminoglycosides, as broad …

Food contaminated with Shiga toxin-producing Escherichia coli (STEC) represents a
hazardous public health problem worldwide. Therefore, the present study was performed to …

Objectives The emergence and spread of carbapenemase-producing Enterobacteriaceae is
a worldwide concern. This study reports the whole genome sequence of an NDM-5-, CTX-M …